Download PDFPDF

Toxic additives in medication for preterm infants
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

  • Published on:
    Alcohol Intake in Infants Treated with Oral Furosemide Solution

    It was with interest that I read the article by Whittaker et al regarding toxic additives in medication for preterm infants, particularly the assessment of alcohol intake in the infant population treated with furosemide oral solution. I was surprised by the statement “ethanol exposure in the preterm infants … ranged from 0.2mL to 1.8mL/ week uncorrected for weight, the equivalent of a 70kg man consuming between 1 and 7...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Additives in medication for preterm infants: documentation of exposure is only the first step…

    Dear editor, We thank Whittaker et al. to refocus on the use of additives in medications by illustrating the incidence and magnitude of exposure in a cohort of preterm neonates.1 We hereby would like to suggest to further extent the adagio of Paracelsus, that ‘all is toxic, it only depends on the dose’, by adding that the ‘recipient’ should also be considered. In addition to their paper, we felt it appropriated to mentio...

    Show More
    Conflict of Interest:
    None declared.